C
Christopher B. Newgard
Researcher at Duke University
Publications - 483
Citations - 55811
Christopher B. Newgard is an academic researcher from Duke University. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 111, co-authored 460 publications receiving 49018 citations. Previous affiliations of Christopher B. Newgard include Durham University & University of Texas at Austin.
Papers
More filters
Book ChapterDOI
Molecular Engineering of Glucose-Regulated Insulin Secretion
TL;DR: In this chapter, recent studies employing molecular approaches for dissecting the relative contributions of glucose transport and glucose phosphorylation in the control of glucose-stimulated insulin release will be reviewed.
Book ChapterDOI
Factors regulating islet regeneration in the post-insulinoma NEDH rat.
Ling Chen,Appel Michael C,Tausif Alam,Chisato Miyaura,Andrea L. Sestak,John O’Neil,Roger H Unger,Christopher B. Newgard +7 more
TL;DR: Differential screening strategies designed at identifying other genes that might be involved in the expansion of β-cell mass are developed, to prevent chronic calcifying pancreatitis.
Journal ArticleDOI
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.
Todd Bradley,Guang Yang,Olga Ilkayeva,T. Matt Holl,Ruijun Zhang,Jinsong Zhang,Sampa Santra,Christopher B. Fox,Steven G. Reed,Robert Parks,Cindy M. Bowman,Hilary Bouton-Verville,Laura L. Sutherland,Richard M. Scearce,Nathan Vandergrift,Thomas B. Kepler,M. Anthony Moody,Hua-Xin Liao,S. Munir Alam,Roger E. McLendon,Jeffrey I. Everitt,Christopher B. Newgard,Laurent Verkoczy,Garnett Kelsoe,Barton F. Haynes +24 more
TL;DR: It is demonstrated that neither the 2F5 bnAb nor HIV MPER-KYNU cross-reactive Abs elicited by immunization with an MPER peptide-liposome vaccine in 2F4 VHDJH and VLJL knock-in mice and rhesus macaques modified KYNU activity or disrupted tissue tryptophan metabolism.
Journal ArticleDOI
Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice
Batuhan Yenilmez,Mark Kelly,Guofang Zhang,Nicole M. Wetoska,Olga Ilkayeva,K. Min,Leslie A. Rowland,Chloe DiMarzio,Wentao He,Naideline Raymond,Lawrence M. Lifshitz,Meixia Pan,Xian-ping Han,Jun Xie,Randall H. Friedline,Jason K. Kim,Guangping Gao,Mark A. Herman,Christopher B. Newgard,Michael P. Czech +19 more
TL;DR: In this article , the relative contributions of these two enzymes to hepatic AcCoA pools and DNL rates in response to high-fat feeding are unknown, however, the hepatocyte ACLY depletion in obese mice paradoxically increased total D2O incorporation into palmitate, whereas in contrast, ACSS2 depletion had no effect.
Patent
Methods for producing insulin in response to non-glucose secretagogues
TL;DR: In this article, the application of genetic engineering to provide artificial β cells, i.e. cells which can secrete insulin in response to glucose, is discussed, which is achieved preferably through the introduction of one or more genes selected from the insulin gene, glucokinase gene and glucose transporter gene, so as to provide an engineered cell having all three of these genes in a biologically functional and responsive configuration.